CELLFINITY
LIVE

Serial Number

79458982

Owner

TQ Therapeutics GmbH

Filing Date

Aug 5, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CELLFINITY Trademark

Serial Number: 79458982

CELLFINITY is a trademark filed by TQ Therapeutics GmbH on August 5, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

TQ Therapeutics GmbH (5 trademarks)

Hermine-von-Parish-Straße 96

Entity Type: 98

Trademark Details

Filing Date

August 5, 2026

Registration Date

Not Registered

Goods & Services

Chemical and biochemical preparations for use in research and laboratories, in particular reagents for pharmacological research, chemical reagents for chromatographic immobilization, purification or isolation of biological materials; chemical reagents for chromatographic immobilization, purification or isolation of cells, in particular body cells and cells of the immune system of mammals including human cells; affinity chromatography reagents used in columns for immobilization, purification or isolation of cells, in particular for immobilization or purification of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and moncytes; chemical reagents for genetically modifying body cells, stem cells and cells of the immune system of mammals including human cells, T-cells, B-cells, natural killer cells and monocytes; chemical reagents for transferring genes into body cells, stem cells, and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes.

Scientific apparatus for the chromatographic immobilization, purification or isolation of biological materials; chromatography columns; scientific apparatus for the chromatographic immobilization, purification or isolations of cells, in particular body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; scientific apparatus for the transfer of genes into body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes.

Scientific services and research relating thereto in the fields of biology, chemistry, medicine, immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, in particular cellular therapy products, including body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes, diagnostic preparations and biomarker reagents and/or diagnostic apparatus.

Pharmaceutical and veterinary preparations, in particular cells, in particular body cells, stem cells, and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; body cells, stem cells, and cells of the immune systems for treatment of cancerous diseases, autoimmune diseases, viral infections or bacterial infections, genetically modified human immune cells, including T-cells, B-cells, natural killer cells or monocytes for treatment of cancerous diseases, autoimmune diseases, viral infections or bacterial infections, in vivo diagnostic reagents for medical purposes.

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 25, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 25, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 24, 2026 REPR